Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| p53-associated regulation of COX17 enhances elesclomol-induced copper-associated cytotoxicity and suppresses gastric cancer growth. | Front Immunol | 2026 | 42375344 | PubTator, text mining | PubMed |
Safety and efficacy of the MNK/VEGFR inhibitor JDB153 combined with the anti-PD-1 antibody serplulimab in patients with advanced pancreatic cancer refractory to standard treatment: a single-arm, phase Ib/II study protocol. | Front Pharmacol | 2026 | 42371576 | PubTator, text mining | PubMed |
| Low Zinc Ameliorated the Decrease in Intestinal Copper Level Induced by Low Dietary Copper: Involvement of SUMOylated-Mtf-1 and Mtf-1/Atp7a Pathway. | FASEB J | 2026 | 42257536 | PubTator, text mining | PubMed |
| FDA approval of copper histidinate (Zycubo) for Menkes disease: a therapeutic breakthrough in a rare pediatric neurodegenerative disorder. | Ann Med Surg (Lond) | 2026 | 42254141 | PubTator, text mining | PubMed |
| Subtype-Specific Alterations in Copper Trafficking Associated with KRAS Mutations in Isogenic Colorectal Cancer Cell Lines. | Biol Trace Elem Res | 2026 | 42230420 | PubTator, text mining | PubMed |
| Prolonged survival in Menkes disease with a novel ATP7A variant: A case report. | World J Clin Pediatr | 2026 | 42220938 | PubTator, text mining | PubMed |
| Successful Treatment of Epileptic Spasms with Perampanel in a Patient with Menkes Disease Caused by a Novel Splice Variant in Intron of ATP7A. | Neuropediatrics | 2026 | 42208591 | PubTator, text mining | PubMed |
| Correction to "Discovery of Imidazo[2,1-b][1,3,4]thiadiazole-Based MNK Inhibitors with Anti-inflammatory Efficacy via Dual Suppression of eIF4E Phosphorylation and NF-κB Signaling". | J Med Chem | 2026 | 42183816 | PubTator, text mining | PubMed |
| Carrier-free GSH-responsive in situ nanoreactor for copper-overload augment cuproptosis/chemodynamic therapy. | Mater Today Bio | 2026 | 42182881 | PubTator, text mining | PubMed |
| Development and Validation of a Cuproptosis-Related Gene Signature for Prognostic Stratification in Papillary Renal Cell Carcinoma. | Clin Lab | 2026 | 42159135 | PubTator, text mining | PubMed |
| A broad-spectrum inhibitor of copper-exporting P1B-type ATPases. | Proc Natl Acad Sci U S A | 2026 | 42133807 | PubTator, text mining | PubMed |
| Distinct signaling mechanisms and proteome phenotypes are elicited by compartment-specific genetic defects of copper homeostasis. | Mol Biol Cell | 2026 | 42126960 | PubTator, text mining | PubMed |
| Development of a Direct-to-Biology Platform to Discover Potent MNK Inhibitors. | J Med Chem | 2026 | 42126237 | PubTator, text mining | PubMed |
| Disorders Mimicking Wilson's Disease: Clinical, Biochemical, and Molecular Perspectives for Accurate Differential Diagnosis. | Diagnostics (Basel) | 2026 | 42122051 | PubTator, text mining | PubMed |
| Drug response profile-based machine learning enables strategic cell line and compound selection for drug development. | Bioinformatics | 2026 | 42103986 | PubTator, text mining | PubMed |
| ATP7A-fibulin-4 complex delivers copper in the Golgi to activate LOX in renal fibrosis. | JCI Insight | 2026 | 42100872 | PubTator, text mining | PubMed |
| Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia. | Leukemia | 2026 | 42092047 | PubTator, text mining | PubMed |
| Copper-histidine therapy: a targeted metabolic intervention for Menkes disease. | Ann Med Surg (Lond) | 2026 | 42078623 | PubTator, text mining | PubMed |
| Could excessive zinc supplementation during pregnancy cause menkes disease? A hypothesis worth investigating. | Front Pediatr | 2026 | 42051949 | PubTator, text mining | PubMed |
| Integrative gene ontology-driven analysis of the eutopic endometrium reveals key dysregulated functionomes and pathways in endometriosis. | J Chin Med Assoc | 2026 | 42037118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=2